SDHA

  • 1 lab in 1 country
  • Funder: National Cancer Institute
  • Humans1

Associations

2

Malignant tumor behavior

upin humans1+47%

1 study
  1. SDHA is associated with malignant tumor behavior in humans (47%).

    Humansin identified tumors in SDHA carriers

    Tumor risks and surveillance outcomes in SDHA variant carriers

    Endocrine oncology (Bristol, England)11 Sep 2026

Tumor incidence

upin humans1+15%

1 study
  1. SDHA is associated with tumor incidence in humans (15%).

    Humansgermline pathogenic or likely pathogenic variantsn = 106

    Tumor risks and surveillance outcomes in SDHA variant carriers

    Endocrine oncology (Bristol, England)11 Sep 2026

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 01 in 12 months